Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > So, Here We Fcukin' Go Again!
View:
Post by Vinny57 on Dec 21, 2020 4:40pm

So, Here We Fcukin' Go Again!

It's getting so you can bank on this once or twice a year.  I am going to say a few things here but you must know I am saying them being long, holding ALL of the shares I have purchased in over  4 years (from $3.65 - $20.00) and never sold.   This Company really has me worried.  The short selling fiasco we went through 2 years ago with Grego and Hindenberg was terrible, but it was not completely the fault of management. (They were somewhat at fault but it was overblown).  We managed to claw our way back, even with Simon at the helm, and until a week ago I thought things looked pretty good for us. ...... and then out of left field BOOM ......... TILRAY!  This is managements fault 100%.   Nobody here wanted that to happen and some made good arguements why it was a good merger. But honestly, who here would have said that Tilray would be a good aquisition a month ago?  The only good arguement I have heard is that would lose the bad stigma associated with the name Aphria. My solution: just change the fcuking name!.  Don't pick up a mess called Tilray.  We don't need a money losing albatross tied around our necks.  We were doing just fine 2 weeks ago without this merger. Tilray now has a lawsuit against them about fiduciary duties. ARE YOU KIDDING ME.  It is the aphria shareholders who are getting fcucked here!

On a side note, two days before the merger news came out I had a dream that Aphria shares had dropped from $9 to pennies in one day due to Aphria's greedy management. A little extreme but was it foreshadowing?  I don't know, but it is strange that we have dropped from over $11 to nearly $9 in a short time. If I had to make a guess as to which one we see first, $12 or $6, at this point I saddly have to say $6. I am still not about to sell as I still have some hope for this company...........but it is getting harder and harder to do.

+Thanks for the thoughts Raptor, GS 
 
V.
Comment by AlbertOyler on Dec 21, 2020 5:01pm
Management must believe that the opportunities that the new company has in the EU and the U.S.A. are looming. OtherwiseTilray will be the proverbiial albatross around Aphrias' neck. 
Comment by blackredblack on Dec 21, 2020 5:04pm
Lowest we go is 8.50...then we bounce BIG. The gap needs to fill IMHO
Comment by Medicalcan on Dec 21, 2020 5:07pm
Waa Waa
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities